10 new cases of COVID-19, on December 10, began recruiting volunteers to test vaccines



[ad_1]

10 new cases of COVID-19, on December 10, began recruiting volunteers to test vaccines - Photo 1.

Sampling for the COVID-19 test – Photo: VIET DUNG

10 new cases (BN1368 – BN1377) are immigration cases, isolated in Khanh Hoa (8 people), Ho Chi Minh City (1 person) and Quang Nam (1 person). As follows:

CASE 1368 (BN1368) in Khanh Hoa: male, 36 years old, Vietnamese nationality, domicile in Vien Noi commune, Ung Hoa district, Hanoi.

CASE 1369 (BN1369) in Khanh Hoa: male, 33 years old, Vietnamese nationality, domicile in Viet Hung neighborhood, Long Bien district, Hanoi.

DISEASE 1370 (BN1370) in Khanh Hoa: male, 22 years old, Vietnamese nationality, domicile in Phu Luong Commune, Phu Vang District, Thua Thien Hue Province.

DISEASE 1371 (BN1371) in Khanh Hoa: male, under 1 year old, Vietnamese nationality, domicile in Thuy Duong Commune, Thuy Nguyen District, Hai Phong City.

DISEASE 1372 (BN1372) in Khanh Hoa: male, 22 years old, Vietnamese nationality, domicile in Tien Ky Commune, Tan Ky District, Nghe An Province.

CASE 1373 (BN1373) in Khanh Hoa: female, 55 years old, Vietnamese nationality, domicile in Cam Son neighborhood, Cam Pha city, Quang Ninh province.

DISEASE 1374 (BN1374) in Khanh Hoa: female, 46 years old, Vietnamese nationality, domicile in Ngoc Son Commune, Hai Duong City, Hai Duong Province.

DISEASE 1375 (BN1375) in Khanh Hoa: male, 21 years old, Vietnamese nationality, domicile in Thai Son Commune, Hiep Hoa District, Bac Giang Province.

On December 5, previous patients from Russia entered Cam Ranh airport on flight QH9195, immediately quarantined, took samples for testing in Khanh Hoa. At 7-12 days, 8 patients tested positive for SARS-CoV-2. Currently, patients are isolated and treated at the Ninh Sim Clinic, Ninh Hoa District, Khanh Hoa Province.

DISEASE 1376 (BN1376) in Ho Chi Minh City: man, 32 years old, Turkish nationality. On December 6, the previous patient from Turkey entered Tan Son Nhat airport on flight TK6470, was immediately quarantined and a sample was taken in Ho Chi Minh City. In the 7-12 day test, 1 patient tested positive for SARS-CoV-2. Currently the patient is isolated and treated at the Cu Chi Field Hospital.

CASE 1377 (BN1377) in Quang Nam: male, 35 years old, Vietnamese nationality, domicile in District 12, District 10, Ho Chi Minh City. On December 6, the previous patient from Japan entered Da Nang Airport on flight VN719, was immediately quarantined, and took samples for testing in Quang Nam City. In the 8-12 day trial, 1 patient it was positive for SARS-CoV-2. The patient is currently in isolation and treated at Quang Nam Central General Hospital.

With 10 new cases, Vietnam has registered 1,377 cases since the beginning of the epidemic, of which 1,224 people were cured and discharged from the hospital.

Mr. Nguyen Ngo Quang, Deputy Director of the Department of Science, Technology and Training of the Ministry of Health, spoke about the upcoming COVID-19 vaccine trial – Video: VIET DNG

According to Nguyen Ngo Quang, deputy director of the Department of Science, Technology and Training of the Ministry of Health, the following people can register to participate in vaccine testing:

1, Volunteer, participate in research according to personal expectations, without any pressure on health, finances, administration …

2, have carefully read and understood the research information sheet, the test principle

3, Have full capacity for behavior, over 18 years

4, healthy, without any acute / chronic disease

5, normal hematological and biochemical indicators

Additionally, there are some specific criteria that will be approved at the 9-12 meeting.

Participants in the study will be able to buy health insurance in accordance with the regulations in force in Vietnam and in the world.

In phase 1 of a human clinical trial, the most important follow-up criterion is the safety score of the vaccine. 40 to 60 people are expected to participate in this round of testing, injecting 2 types of expected doses of 50 mg and 75 mg.

[ad_2]